Due to mutation, amplification, deletion, methylation and post-translational modifications, mTOR overactivation in NSCLC is essential for tumorigenesis, cancer progression and therapy resistance, and is often associated with poor prognosis69,70. This evidence concerns the gene MTOR and non-small cell lung carcinoma.